Extracellular matrix-cell interactions: Focus on therapeutic applications

dc.contributor.authorA. Sainio
dc.contributor.authorH. Jarvelainen
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code2607100
dc.converis.publication-id45578015
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/45578015
dc.date.accessioned2022-10-28T14:29:11Z
dc.date.available2022-10-28T14:29:11Z
dc.description.abstractExtracellular matrix (ECM) macromolecules together with a multitude of different molecules residing in the extracellular space play a vital role in the regulation of cellular phenotype and behavior. This is achieved via constant reciprocal interactions between the molecules of the ECM and the cells. The ECM-cell interactions are mediated via cell surface receptors either directly or indirectly with co-operative molecules. The ECM is also under perpetual remodeling process influencing cell-signaling pathways on its part. The fragmentation of ECM macromolecules provides even further complexity for the intricate environment of the cells. However, as long as the interactions between the ECM and the cells are in balance, the health of the body is retained. Alternatively, any dysregulation in these interactions can lead to pathological processes and finally to various diseases. Thus, therapeutic applications that are based on retaining normal ECM-cell interactions are highly rationale. Moreover, in the light of the current knowledge, also concurrent multi-targeting of the complex ECM-cell interactions is required for potent pharmacotherapies to be developed in the future.
dc.identifier.eissn1873-3913
dc.identifier.jour-issn0898-6568
dc.identifier.olddbid188554
dc.identifier.oldhandle10024/171648
dc.identifier.urihttps://www.utupub.fi/handle/11111/53779
dc.identifier.urnURN:NBN:fi-fe2021042826783
dc.language.isoen
dc.okm.affiliatedauthorSainio, Annele
dc.okm.affiliatedauthorJärveläinen, Hannu
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherELSEVIER SCIENCE INC
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumberARTN 109487
dc.relation.doi10.1016/j.cellsig.2019.109487
dc.relation.ispartofjournalCellular Signalling
dc.relation.volume66
dc.source.identifierhttps://www.utupub.fi/handle/10024/171648
dc.titleExtracellular matrix-cell interactions: Focus on therapeutic applications
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S0898656819302839-main.pdf
Size:
1.36 MB
Format:
Adobe Portable Document Format